חזרה לתוצאות החיפוש

A Study of GLB-001 in Patients With Myeloid Malignancies

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Polycythemia Vera · Essential Thrombocythemia · Myelofibrosis · Myelodysplastic Syndromes · Acute Myeloid Leukemia · Myeloid Malignancy

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, Anhui, China

    Contact: Study coordinator (Xiaoyu Zhu, MD) · 86-0551-62283160

  • China-Japan Friendship Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Zhenling Li, MD) · 86-010-84205566

  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Li Wang, MD) · 86-023-68811360

  • The First Hospital of Hebei Medical Universtiy, Shijiazhuang, Hebei, China

    Contact: Study coordinator (Qingchi Liu, MD) · 86-0311-85917000

  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Hu Zhou, MD) · 86-0371-65587320

  • Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

    Contact: Study coordinator (Xuelan Zuo, MD) · 86-027-67812888

  • The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

    Contact: Study coordinator (Miao Miao, MD) · 86-0512-65223637

  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Fei Li, MD) · 86-0791-88603000

  • Sheng Jing Hospital of China Medical Universtiy, Shenyang, Liaoning, China

    Contact: Study coordinator (Wei Yang, MD) · 86-024-96615

  • Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Wei Wang, MD) · 86-021-52889999
    Guoying Cao, MD (Sub-investigator)

  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Lei Zhang, MD) · 86-022-23909240

  • The Second Hospital of Tianjin Medical Universtiy, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Jie Bai, MD) · 86-022-88328832

  • The First Affilicated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Hongyan Tong, MD) · 86-0571-87236114

  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

    Contact: Study coordinator (Songfu Jiang, MD) · 86-0577-55578532
מובילי המחקר

  • Gang Lu, Ph.D.

    Study Director

    Hangzhou GluBio Pharmaceutical Co., Ltd.

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)